ՄԵԸՔ մանրամասներ
| 000 -LEADER |
|---|
| fixed length control field |
01033nam a2200265 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
000676276 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20170516142249.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
090729s1997 ||||||||r|||||000|0|eng|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0-7923-8718-X |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Trends in inflammatory bowel disease therapy 1996 / |
| Statement of responsibility, etc. |
Axcan Pharma, Inc.; edited by R.S. McLeod [et al.]. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Dordrecht [etc.] : |
| Name of publisher, distributor, etc. |
Kluwer Academic Publishers, |
| Date of publication, distribution, etc. |
1997. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 292 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
"The proceedings of a symposium organised by AXCAN PHARMA, held in Ottawa, June 12-15, 1996" |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Inflammatory bowel diseases |
| General subdivision |
Congresses |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Inflammatory Bowel Diseases |
| General subdivision |
therapy |
| -- |
congresses |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Crohn Disease |
| General subdivision |
therapy |
| -- |
congresses |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Colitis, Ulcerative |
| General subdivision |
therapy |
| -- |
congresses |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
McLeod, Robin S. |
| Relator term |
edt |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Martin, F. |
| Relator term |
edt |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sutherland, L.R. |
| Relator term |
edt |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wallace, J.L. |
| Relator term |
edt |
| 710 1# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Axcan Pharma, Inc. |
